These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38879469)

  • 21. Marijuana use is inversely associated with liver steatosis detected by transient elastography in the general United States population in NHANES 2017-2018: A cross-sectional study.
    Du R; Tang XY; Yang C; Gao WH; Gao SJ; Xiang HJ; Yang L
    PLoS One; 2023; 18(5):e0284859. PubMed ID: 37200309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the association between theobromine intake and hepatic steatosis in young people.
    Kong Y; Han L; Zhu Z; Chen X
    Sci Rep; 2024 Jun; 14(1):12922. PubMed ID: 38839921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of transient elastography to assess hepatic steatosis and fibrosis in patients with juvenile idiopathic arthritis during methotrexate treatment.
    Niyasom C; Soponkanaporn S; Vilaiyuk S; Lertudomphonwanit C; Getsuwan S; Tanpawpong P; Kaewduang P; Sobhonslidsuk A
    Clin Rheumatol; 2024 Jan; 43(1):423-433. PubMed ID: 38062311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of hepatic steatosis and liver fibrosis with chronic obstructive pulmonary disease among adults.
    Zheng D; Liu X; Zeng W; Zhou W; Zhou C
    Sci Rep; 2024 May; 14(1):10822. PubMed ID: 38734742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between cardiometabolic index and hepatic steatosis and liver fibrosis: a population-based study.
    Cheng L; Wu Q; Wang S
    Hormones (Athens); 2024 Sep; 23(3):477-486. PubMed ID: 38861108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome.
    Kuo TC; Lu YB; Yang CL; Wang B; Chen LX; Su CP
    BMC Gastroenterol; 2024 Jan; 24(1):26. PubMed ID: 38195414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between hepatic steatosis and fibrosis and arthritis among US adults: A population-based study.
    Lu Z; Wu S; Feng E; Chen X; Chen J; Lin F
    Clinics (Sao Paulo); 2024; 79():100378. PubMed ID: 38875754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between atherogenic index of plasma and metabolic dysfunction-associated fatty liver disease as detected by FibroScan.
    Wang A; Li J; Li L; Ding H; Yang N; Xu M
    Nutr Hosp; 2024 Apr; 41(2):384-392. PubMed ID: 38328923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cadmium is associated with hepatic steatosis and fibrosis: Korean national health and nutrition examination survey data IV-VII.
    Han S; Sung GH; Lee S; Han KJ; Han HJ
    Medicine (Baltimore); 2022 Jan; 101(4):e28559. PubMed ID: 35089193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inverted U-shaped relationships between bone mineral density and VCTE-quantified degree of hepatic steatosis in adolescents: Evidence from the NHANES.
    He S; Zhang Y; Tan C; Tan W; Yin B
    PLoS One; 2023; 18(6):e0286688. PubMed ID: 37294745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.
    Unger LW; Forstner B; Muckenhuber M; Scheuba K; Eigenbauer E; Scheiner B; Pfisterer N; Paternostro R; Trauner M; Mandorfer M; Reiberger T
    Dig Dis Sci; 2020 Sep; 65(9):2712-2718. PubMed ID: 31875288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between frailty and hepatic fibrosis in NAFLD among middle-aged and older adults: results from NHANES 2017-2020.
    Atabieke F; Li XJ; Aierken A; Li J; Zhang Y; Aizezi Y; Gao HL; Zhang ZQ
    Front Public Health; 2024; 12():1330221. PubMed ID: 38389936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis.
    Bader RM; Jonas MM; Mitchell PD; Wiggins S; Lee CK
    J Cyst Fibros; 2019 Mar; 18(2):280-285. PubMed ID: 30509601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study.
    Cardoso CRL; Villela-Nogueira CA; Leite NC; Salles GF
    Cardiovasc Diabetol; 2021 Sep; 20(1):193. PubMed ID: 34560854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis.
    Shen F; Mi YQ; Xu L; Liu YG; Wang XY; Pan Q; Zhang RN; Hu XQ; Xu LM; Fan JG
    Aliment Pharmacol Ther; 2019 Jul; 50(1):93-102. PubMed ID: 31094016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017-2018.
    Yang Z; Gong D; He X; Huang F; Sun Y; Hu Q
    Front Nutr; 2023; 10():1113789. PubMed ID: 36860686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of liver stiffness and controlled attenuation parameter measured by transient elastography with diabetes mellitus in patients with chronic liver disease.
    Ahn JM; Paik YH; Kim SH; Lee JH; Cho JY; Sohn W; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    J Korean Med Sci; 2014 Aug; 29(8):1113-9. PubMed ID: 25120322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis.
    Trivedi HD; Niezen S; Jiang ZG; Tapper EB
    Dig Dis Sci; 2022 Aug; 67(8):4215-4222. PubMed ID: 34417922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the composite dietary antioxidant index and metabolic dysfunction-associated steatotic liver disease in adults: a cross-sectional study from NHANES 2017-2020.
    Yang Z; Song S; Li L; Yuan Z; Li Y
    Sci Rep; 2024 Jun; 14(1):13801. PubMed ID: 38877074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.